The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...
AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results